29, no. 9 (сентябрь 2010): 1139–1145, doi: 10.1007/s100960100979-y.
52. Shahla Amri Saroukolaei et al., “The Role of Candida Albicans in the Severity of Multiple Sclerosis,” Mycoses 59, no. 11 (ноябрь 2016): 697–704, doi: 10.1111/myc.12489.
53. Romain Gerard et al., “An Immunological Link Between Candida Albicans Colonization and Crohn’s Disease,” Critical Reviews in Microbiology 41, no. 2 (июнь 2015): 135–139, doi: 10.3109/1040841X.2013.810587.
54. Lerner Aaron and Matthias Torsten, “Candida Albicans in Celiac Disease: A Wolf in Sheep’s Clothing,” Autoimmunity Reviews 19, no. 9 (сентябрь 2020): 102621, doi: 10.1016/j.autrev.2020.102621.
55. Matthew L. Wheeler et al., “Immunological Consequences of Intestinal Fungal Dysbiosis,” Cell Host & Microbe 19, no. 6 (8 июня 2016): 865–873, doi: 10.1016/j.chom.2016.05.003.
56. Mafalda Cavalheiro and Miguel Cacho Teixeira, “Candida Biofilms: Threats, Challenges, and Promising Strategies,” Frontiers in Medicine 5 (2018): 28, doi: 10.3389/fmed.2018.00028.
57. HansCurt Flemming et al., “Biofilms: An Emergent Form of Bacterial Life,” Nature Reviews Microbiology 14, no. 9 (11 августа 2016): 563–575, doi: 10.1038/nrmicro.2016.94.
58. Lindsay Kalan et al., “Redefining the ChronicWound Microbiome: Fungal Communities Are Prevalent, Dynamic, and Associated with Delayed Healing,” mBio 7, no. 5 (сентябрь – октябрь 2016): e01058–16, doi: 10.1128/mBio.01058-16.
59. Voon Kin Chin et al., “Mycobiome in the Gut: A Multiperspective Review,” Mediators of Inflammation 2020 (4 апреля 2020), doi: 10.1155/2020/9560684.
60. Pedro H. GazzinelliGuimaraes and Thomas B. Nutman, “Helminth Parasites and Immune Regulation,” F1000Research 7 (23 октября 2018): F1000 Faculty Rev1685, doi: 10.12688 / f1000research.15596.1.
61. Anne M. Ercolini and Stephen D. Miller, “The Role of Infections in Autoimmune Disease,” Clinical & Experimental Immunology 155, no. 1 (январь 2009): 1–15, doi: 10.1111/j.13652249.2008.03834.x.
62. Laura Eme and W. Ford Doolittle, “Archaea,” Current Biology 25, no. 19 (5 октября 2015): R851–855, doi: 10.1016/j.cub.2015.05.025.
63. Katelyn E. Madigan, Richa Bundy, and Richard B. Weinberg, “Distinctive Clinical Correlates of Small Intestinal Bacterial Overgrowth with Methanogens,” Clinical Gastroenterology and Hepatology (29 сентября 2021), doi: 10.1016/j.cgh.2021.09.035.
64. Erika Ruback Bertges and Júlio Maria Fonseca Chebli, “Prevalence and Factors Associated with Small Intestinal Bacterial Overgrowth in Patients with Crohn’s Disease: A Retrospective Study at a Referral Center,” Arquivos de Gastroenterologia 57, no. 3 (июль – сентябрь 2020): 283–288, doi: 10.1590/S00042803.202000000-64.
65. Jeremy Liu Chen Kiow et al., “High Occurrence of Small Intestinal Bacterial Overgrowth in Primary Biliary Cholangitis,” Neurogastroenterology & Motility 31, no. 11 (ноябрь 2019): e13691, doi: 10.1111/nmo.13691.
1. Arun Parashar and Malairaman Udayabanu, “Gut Microbiota Regulates Key Modulators of Social Behavior,” European Neuropsychopharmacology 26, no. 1 (январь 2016): 78–91, doi: 10.1016/j.euroneuro.2015.11.002.
2. Zachary Blount, “The Unexhausted Potential of E. Coli,” eLife 4 (2015): e05826, doi: 10.7554 /eLife.05826.
3. Jack Gilbert et al., “Current Understanding of the Human Microbiome,” Nature Medicine 24, no. 4 (10 апреля 2018): 392–400, doi: 10.1038/nm.4517.
4. Sylvie Miquel, “Faecalibacterium prausnitzii and Human Intestinal Health,” Current Opinion in Microbiology 16, no. 3 (июнь 2013): 255–261, doi: 10.1016/j.mib.2013.06.003.
5. Yun Kit Yeoh et al., “Gut Microbiota Composition Reflects Disease Severity and Dysfunctional Immune Responses in Patients with COVID-19,” Gut 70, no. 4 (апрель 2021): 698–706, doi; 10.1136/gutjnl2020323020.
6. Tao Zuo et al., “Alterations in Gut Microbes of Patients with COVID-19 During Time of Hospitalization,” Gastroenterology 159, no. 3 (сентябрь 2020): 944–955, doi: 10.1053/j.gastro.2020.05.048.
7. Alison N. Thorburn, Laurence Macia, and Charles R. Mackay, “Diet, Metabolites, and ‘WesternLifestyle’ Inflammatory Diseases,” Immunity 40, no. 6 (19 июня 2014): 833–842, doi: 10.1016/j.immuni.2014.05.014.
8. Omaida C. Velázquez, Howard M. Lederer, John L. Rombeau, “Butyrate and the Colonocyte. Production, Absorption, Metabolism, and Therapeutic Implications,” Advances in Experimental Medicine and Biology 427 (1997): 123–134, https://pubmed.ncbi.nlm.nih.gov/9361838/.
9. Hu Liu et al., “Butyrate: A DoubleEdged Sword for Health?”, Advances in Nutrition 9, no. 1 (январь 2018): 21–29, doi: 10.1093/advances/nmx009.
10. Petra Louis and Harry J. Flint, “Formation of Propionate and Butyrate by the Human Colonic Microbiota,” Environmental Microbiology 19, no. 1 (январь 2017): 29–41, doi: 10.1111/14622920.13589.
11. Jindong Zhang et al., “Beneficial Effect of ButyrateProducing Lachnospiraceae on StressInduced Visceral Hypersensitivity in Rats,” Journal of Gastroenterology and Hepatology 34, no. 8 (август 2019): 1368–1376, doi: 10.1111/jgh.14536.
12. Roman M. Stilling et al., “The Neuropharmacology of Butyrate: The Bread and Butter of the MicrobiotaGutBrain Axis?”, Neurochemistry International 99 (октябрь 2016): 110–132, doi: 10.1016/j.neuint.2016.06.011.
13. Tennekoon B. Karunaratne et al., “Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson’s Disease,” Nutrients 13, no. 1 (январь 2021): 28, doi: 10.3390/nu13010028.
14. Miquel, “Faecalibacterium prausnitzii,” 255–261.
15. Harry Sokol et al., “Faecalibacterium prausnitzii is an AntiInflammatory Commensal Bacterium Identified by Gut Microbes Analysis of Crohn Disease Patients,” Proceedings of the National Academy of Sciences of the United States of America 105, no. 43 (28 октября 2008): 16731–16736, doi: 10.1073/pnas.0804812105.
16. Mireia LopezSiles et al., “Faecalibacterium prausnitzii: From Microbiology to Diagnostics and Prognostics,” The ISME Journal 11, no. 4 (апрель 2017): 841–852, doi: 10.1038/ismej.2016.176.
17. Patrice D. Cani and William M. de Vos, “NextGeneration Beneficial Microbes: The Case of Akkermansia muciniphila,” Frontiers in Microbiology 8 (2017): 1765, doi: 10.3389 /fmicb.2017.01765.
18. Muriel Derrien et al., “Akkermansia,” in Bergey’s Manual of Systematics of Archaea and Bac teria, ed. William B. Whitman (Hoboken, NJ: John Wiley & Sons, Inc., 2015), doi: 10.1002/9781118960608.gbm01282.
19. Kequan Zhou, “Strategies to Promote Abundance of Akkermansia muciniphila, an Emerging Probiotics in the Gut, Evidence from Dietary Intervention Studies,” Journal of Functional Foods 33 (июнь 2017): 194–201, doi: 10.1016/j.jff.2017.03.045.
20. Hubert Plovier et al., “A Purified Membrane Protein from Akkermansia muciniphila or the Pasteurized Bacterium Improves Metabolism in Obese and Diabetic Mice,” Nature Medicine 23, no. 1 (январь 2017): 107–113, doi: 10.1038/nm.4236.
21. Yuji Naito, Kazuhiko Uchiyama, and Tomohisa Takagi, “A Nextgeneration Beneficial Microbe: Akkermansia muciniphila,” Journal of Clinical Biochemistry and Nutrition 63, no. 1 (июль 2018): 33–35, doi: 10.3164/jcbn.18–57.
22. Cani, “NextGeneration Beneficial Microbes,” 1765.
23. Kouichi Miura and Hirohide Ohnishi, “Role of Gut Microbes and Tolllike Receptors in Non-alcoholic Fatty Liver Disease,” World Journal of Gastroenterology 20, no. 23 (21 июня 2014): 7381–7391, doi: 10.3748/wjg.v20.i23.7381.
24. Maria Carlota Dao et al., “Akkermansia muciniphila and Improved Metabolic Health during a Dietary Intervention in Obesity: Relationship with Gut Microbiome Richness and Ecology,” Gut 65, no. 3 (март 2016): 426–436, doi: 10.1136/gutjnl2014308778.
25. Arun P. Lakshmanan et al., “Akkermansia, a Possible Microbial Marker for Poor Glycemic Control in Qataris Children Consuming Arabic Diet— A Pilot Study on Pediatric T1DM in Qatar.” Nutrients vol. 13, no. 3 (2021): 836, doi: 10.3390/nu13030836.
26. Rapat Pittayanon et al., “Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review,” Gastroenterology 158 (2020): 930–946.e1, doi: 10.1053/j.gastro.2019.11.294.
27. Huajun Zheng et al., “Altered Gut Microbiota Composition Associated with Eczema in Infants,” PLoS One 11, no. 11 (2016): e0166026, doi: 10.1371/journal.pone.0166026.
28. Y Wu et al., “Breast Milk Flora Plays an Important Role in Infantile Eczema: Cohort Study in Northeast China,” Journal of Applied Microbiology 131 (2021): 2981–2993, doi: 10.1111 / jam.15076.
29. Angelina Volkova et al., “Predictive Metagenomic Analysis of Autoimmune Disease Identifies Robust Autoimmunity and DiseaseSpecific Microbial Signatures,” Frontiers in Microbiology 12 (2021): 621310, doi: 10.3389/fmicb.2021.621310.
30. Ali Mirza et al., “The Multiple Sclerosis Gut Microbiota: A Systematic Review,” Mult Scler Relat Disord 37 (2020): 101427, doi: 10.1016/j.msard.2019.101427.
31. Zhou, “Strategies,” 194–201.
32. Pittayanon et al., “Differences,” 930–946.e1.
33. Cani, “NextGeneration Beneficial Microbes,” 1765.
34. Claire Depommier et al., “Supplementation with Akkermansia muciniphila in Overweight and Obese Human Volunteers: A Proof-of-Concept Exploratory Study,” Nature Medicine 25, no. 7 (июль 2019): 1096–1103, doi: 10.1038/s415910190495-2.
35. Claire Depommier et al., “Supplementation with Akkermansia muciniphila in Overweight and Obese Human Volunteers: A Proof-of-Concept Exploratory Study,”